Source:http://linkedlifedata.com/resource/pubmed/id/17458878
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2007-8-2
|
pubmed:abstractText |
Analysis of SNPs for association, linkage, haplotype, and pharmacogenetic studies has led to a dramatic increase in the number and evolution of medium- to high-throughput genotyping technologies. This study introduces Plexor as a new method for medium-throughput (single SNP) genotyping. We compare this fluorescent-based chemistry for call rate, accuracy, affordability, throughput, and overall efficiency against two commonly used technologies. These include fluorescent-based TaqMan allelic discrimination for single SNP analysis (medium-throughput) and the homogenous MassEXTEND (hME) chemistry using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry for multiple SNP analysis (high-throughput). Analysis of 11 SNPs, including all six possible nucleotide substitutions, showed Plexor to be highly comparable for both call rate (94.7%) and accuracy (99.2%) to the TaqMan (94.6% and 99.8%, respectively) and hME (91.9% and 98.1%, respectively) chemistries. We demonstrate that this novel method is an efficient, cost-effective alternative to TaqMan genotyping commonly used in diagnostic settings.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/IL1RN protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/IL4 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/IL6 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin 1 Receptor Antagonist...,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-4,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-8
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1098-1004
|
pubmed:author | |
pubmed:copyrightInfo |
(c) 2007 Wiley-Liss, Inc.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
922-7
|
pubmed:meshHeading |
pubmed-meshheading:17458878-DNA Mutational Analysis,
pubmed-meshheading:17458878-Genotype,
pubmed-meshheading:17458878-Humans,
pubmed-meshheading:17458878-Interleukin 1 Receptor Antagonist Protein,
pubmed-meshheading:17458878-Interleukin-2,
pubmed-meshheading:17458878-Interleukin-4,
pubmed-meshheading:17458878-Interleukin-6,
pubmed-meshheading:17458878-Interleukin-8,
pubmed-meshheading:17458878-Models, Biological,
pubmed-meshheading:17458878-Polymerase Chain Reaction,
pubmed-meshheading:17458878-Polymorphism, Single Nucleotide,
pubmed-meshheading:17458878-Reproducibility of Results,
pubmed-meshheading:17458878-Sensitivity and Specificity,
pubmed-meshheading:17458878-Spectrometry, Mass, Matrix-Assisted Laser...
|
pubmed:year |
2007
|
pubmed:articleTitle |
Novel Plexor SNP genotyping technology: comparisons with TaqMan and homogenous MassEXTEND MALDI-TOF mass spectrometry.
|
pubmed:affiliation |
Cancer Research Program, Garvan Institute of Medical Research, St Vincent's Hospital, Sydney, Australia.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|